Clinical relevance of CD44 surface expression in advanced stage serous epithelial ovarian cancer: a prospective study

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma

(2015) Claire Bonneau et al.   GYNECOLOGIC ONCOLOGY

Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer

(2015) Yan Gao et al.   Oncotarget

High Expression of Lewis y Antigen and CD44 Is Correlated with Resistance to Chemotherapy in Epithelial Ovarian Cancers

(2013) Zhenhua Hu et al.   PLoS One

Overexpression of Lewis (y) Antigen Protects Ovarian Cancer RMG-1 Cells from Carboplatin-Induced Apoptosis by the Upregulation of Topo-I and Topo-II β

(2011) Changzhi Wang et al.   Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology

Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer

(2011) R. Wendel Naumann et al.   DRUGS

Clinical Trials in Recurrent Ovarian Cancer

(2011) Michael Friedlander et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Enhancive effects of Lewis y antigen on CD44-mediated adhesion and spreading of human ovarian cancer cell line RMG-I

(2011) Lili Gao et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

(2009) Andreas du Bois et al.   CANCER

Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors

(2008) S. Zhang et al.   CANCER RESEARCH

Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells

(2008) T Baba et al.   ONCOGENE

Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression

(2008) Lilly Y.W. Bourguignon   SEMINARS IN CANCER BIOLOGY